Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Emanuele Focà and Andrea Antinori.
Emanuele Focà
Connection Strength
0.433
Andrea Antinori
  1. Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study. J Infect Dis. 2021 01 04; 223(1):28-37.
    View in: PubMed
    Score: 0.115
  2. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses. Clin Infect Dis. 2021 11 02; 73(9):e3019-e3026.
    View in: PubMed
    Score: 0.061
  3. Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J Infect. 2021 04; 82(4):e4-e7.
    View in: PubMed
    Score: 0.058
  4. Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Ann Neurol. 2020 08; 88(2):423-427.
    View in: PubMed
    Score: 0.055
  5. Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? AIDS. 2019 03 15; 33(4):759-762.
    View in: PubMed
    Score: 0.051
  6. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. J Antimicrob Chemother. 2018 07 01; 73(7):1955-1964.
    View in: PubMed
    Score: 0.048
  7. Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). J Antimicrob Chemother. 2017 04 01; 72(4):1163-1171.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.